REG - Indivior PLC - Indivior to Participate in Investor Events

IndiviorAnnouncement

06/09/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220906:nRSF4945Ya&default-theme=true

RNS Number : 4945Y  Indivior PLC  06 September 2022

 

 

Indivior To Participate In Upcoming Investor Events

 

Slough, UK, and Richmond, VA, September 6, 2022 - Indivior PLC (LON: INDV)
today announced that it will participate in the following investor events:

 

·    Morgan Stanley 20(th) Annual Global Healthcare Conference - New York

Mark Crossley, Chief Executive Officer (CEO), will host 1x1/group meetings on
Monday, September 12(th) and participate in a fireside chat at 8:10 a.m. US
EST.  Investors can contact their Morgan Stanley representative to schedule a
meeting.  The fireside chat can be viewed using the following weblink:
Indivior PLC - 1566921 (webcasts.com)
(https://event.webcasts.com/starthere.jsp?ei=1566921&tp_key=e0dfc4ed65&tp_special=8)

 

·    Bank of America Global Healthcare Conference 2022 - London

Mark Crossley, CEO, will host 1x1/group meetings on Thursday and Friday,
September 15(th) and 16(th) and host a presentation September 16(th) at 13:20
(BST) (8:20 a.m. US EST).  Investors can contact their Bank of America
representative to schedule a meeting.  The presentation will be available at
www.indivior.com (http://www.indivior.com) and can also be viewed using the
following webcast link: Indivior PLC - BOA Webcast
(https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2022/id9cG96q.cfm)

 

·    Jefferies Global Healthcare Fireside Chat Series - Virtual

Mark Crossley, CEO, will participate in a fireside chat on Wednesday,
September 21(st) at 16:30 (BST) (11:30 a.m. US EST).  The fireside chat can
be viewed using the following weblink: Webinar Registration - Zoom
(https://jefferies.zoom.us/webinar/register/WN_thq9Pe4kSX6C5xEJxJbFxw)

 

 

 

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD) and
serious mental illnesses. Our vision is that all patients around the world
will have access to evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from
a global human crisis to a recognized and treated chronic disease. Building on
its global portfolio of OUD treatments, Indivior has a pipeline of product
candidates designed to both expand on its heritage in this category and
potentially address other chronic conditions and co-occurring disorders of
SUD, including alcohol use disorder and cannabis use disorder. Headquartered
in the United States in Richmond, VA, Indivior employs approximately 1,000
individuals globally and its portfolio of products is available in over 40
countries worldwide. Visit www.indivior.com
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.indivior.com%2F&data=04%7C01%7Cjason.thompson%40Indivior.com%7C50524c1bfa284722f7ee08da13118474%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C637843263192018647%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=XV57BWLOjOnGhAQJWI0WKEK4%2FXf0M9QcOEiYwwerqho%3D&reserved=0)
to learn more. Connect with Indivior on LinkedIn by visiting
www.linkedin.com/company/indivior
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Findivior&data=04%7C01%7Cjason.thompson%40Indivior.com%7C50524c1bfa284722f7ee08da13118474%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C637843263192018647%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=ztGNJPoRRJvCmxgR2tqSP1oJuDdNpAGH7hPFUtuOHcA%3D&reserved=0)
.

 

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFSEAFIRIIF